Elanco (ELAN) CFO boosts stake with 4,200-share buy and new Deferred Stock Units
Rhea-AI Filing Summary
Elanco Animal Health EVP and CFO Robert M. VanHimbergen reported two transactions on August 7, 2026. He received a grant of 8.9069 Deferred Stock Units, each representing the right to one share of common stock or cash, bringing his Deferred Stock Unit balance to 133.6048. On the same date, he purchased 4,200 shares of common stock in multiple transactions at a weighted average price of $23.0776 per share, with individual prices ranging from $23.01 to $23.09. Following these purchases, he directly owns 137,516 shares of Elanco Animal Health common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 4,200 shares
Net Buy
2 txns
Insider
VanHimbergen Robert M
Role
EVP and CFO
Bought
4,200 shs ($97K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Stock Units F2, F3 | 8.9069 | $22.12 | $197.02 |
| Purchase | Common Stock F1 | 4,200 | $23.0776 | $97K |
Holdings After Transaction:
Deferred Stock Units — 133.6048 shares (Direct);
Common Stock — 137,516 shares (Direct)
Footnotes (3)
- F1. Reflects the weighted average price of 4,200 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 7, 2026 with purchase prices ranging from $23.01 to $23.09 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- F2. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
- F3. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Key Figures
Common shares purchased: 4,200 shares
Weighted average purchase price: $23.0776 per share
Common shares held after transaction: 137,516 shares
+2 more
5 metrics
Common shares purchased
4,200 shares
Open-market purchases on August 7, 2026 by EVP and CFO
Weighted average purchase price
$23.0776 per share
Multiple trades between $23.01 and $23.09 on August 7, 2026
Common shares held after transaction
137,516 shares
Direct ownership after August 7, 2026 purchases
Deferred Stock Units granted
8.9069 units
Grant of Deferred Stock Units on August 7, 2026
Deferred Stock Units balance
133.6048 units
Deferred Stock Units directly held after grant
Key Terms
Deferred Stock Units, weighted average price, Executive Deferral and Stock Match Plan
3 terms
Deferred Stock Units financial
"Each deferred stock unit represents the right to receive one share of Company common stock"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
weighted average price financial
"Reflects the weighted average price of 4,200 shares of common stock"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Executive Deferral and Stock Match Plan financial
"in accordance with Executive Deferral and Stock Match Plan"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Elanco Animal Health (ELAN) report for Robert M. VanHimbergen?
Elanco Animal Health reported that EVP and CFO Robert M. VanHimbergen received 8.9069 Deferred Stock Units and purchased 4,200 shares of common stock on August 7, 2026, in open-market transactions.
What are the CFO’s Elanco (ELAN) common stock holdings after these transactions?
After the reported purchases, Robert M. VanHimbergen directly holds 137,516 shares of Elanco Animal Health common stock, according to the Form 4 reporting his August 7, 2026 transactions.
What Deferred Stock Units did the Elanco (ELAN) CFO receive?
He received 8.9069 Deferred Stock Units, each representing the right to receive one share of common stock or the cash equivalent, increasing his Deferred Stock Unit balance to 133.6048 units.
When will the Elanco (ELAN) Deferred Stock Units for the CFO settle?
The Deferred Stock Units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, under the Executive Deferral and Stock Match Plan.